Ratings by Piper Sandler (Steven Mah)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/17/2021 | Cytek Biosciences Inc | CTKB | New Coverage | Overweight (N/A) |
20.67 (5.63) |
-72.76% | Details | |
| 8/12/2021 | Talis Biomedical Corp. | tlis | Downgrade | Neutral (Overweight) |
8.97 (8.61) |
-4.01% | Details | |
| 8/9/2021 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 7/6/2021 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/11/2021 | Akoya Biosciences Inc | AKYA | New Coverage | Overweight (N/A) |
19.75 (3.80) |
-80.76% | Details | |
| 4/12/2021 | Codexis, Inc. | CDXS | New Coverage | Overweight (N/A) |
24.62 (2.67) |
-89.16% | Details | |
| 4/12/2021 | Twist Bioscience | TWST | New Coverage | Overweight (N/A) |
132.32 (30.48) |
-76.96% | Details | |
| 3/9/2021 | Talis Biomedical Corp. | TLIS | New Coverage | Overweight (N/A) |
14.65 (8.61) |
-41.23% | Details | |
| 2/8/2021 | Meridian Biosciences | VIVO | Maintain | Overweight (N/A) |
|
Details | ||
| 1/12/2021 | CareDx, Inc | CDNA | Maintain | Overweight (N/A) |
|
Details | ||
| 1/7/2021 | Oxford Immunotec | OXFD | Downgrade | Neutral (Overweight) |
17.29 (21.99) |
27.18% | Details | |
| 12/18/2020 | Oxford Immunotec | OXFD | Maintain | Overweight (N/A) |
|
Details | ||
| 12/16/2020 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/16/2020 | Meridian Biosciences | VIVO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2020 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2020 | Oxford Immunotec | OXFD | New Coverage | Overweight (N/A) |
13.91 (21.99) |
58.09% | Details | |
| 8/11/2020 | Meridian Biosciences | VIVO | New Coverage | Overweight (N/A) |
19.32 (33.97) |
75.83% | Details | |
| 8/5/2020 | Fulgent Genetics | FLGT | Maintain | Overweight (N/A) |
|
Details | ||
| 7/27/2020 | Fulgent Genetics | FLGT | Maintain | Overweight (N/A) |
|
Details | ||
| 6/17/2020 | Fulgent Genetics | FLGT | New Coverage | Overweight (N/A) |
16.50 (20.13) |
22% | Details | |
| 6/9/2020 | Natera | NTRA | New Coverage | Overweight (N/A) |
41.23 (90.01) |
118.31% | Details |
